Review of Robotic Surgery Platforms and End Effectors

The document reviews various surgical robots, their features, costs, and effectiveness in minimally invasive surgery. It discusses the benefits of robotic surgery, such as shorter recovery time and less infection risk for patients, and reduced fatigue for surgeons, but also notes the higher costs and increased stress for surgeons due to the loss of direct patient contact. The document provides a comprehensive review of various surgical robot manufacturers and their products, including Accuray Incorporated, Asensus Surgical, Auris Health Inc., and others. It also discusses the various end effectors used in these robotic systems. The document reviews three robotic surgery platforms: XACT Robotic System, Preceyes from ZEISS, and ROSA ONE® from Zimmer Biomet Holdings Inc. These systems offer high degrees of accuracy and precision, leading to improved surgical results and faster patient recovery times. The document also discusses the trade-offs between reusable, disposable, and reposable end effectors, noting the growing interest in developing new steering concepts for reusable instruments and in hospital policies favoring the use of reusable or recyclable instruments.